Results 241 to 250 of about 90,738 (349)
De novo TANC2 stop‐loss variant associated with developmental impairment and drug‐resistant epilepsy
Epileptic Disorders, EarlyView.
Matthew A. Hintermayer, Kenneth A. Myers
wiley +1 more source
Cognition in adults with bottom‐of‐sulcus dysplasia and the consequences of focal resection
Abstract Objective To determine whether there are cognitive consequences of bottom‐of‐sulcus dysplasia (BOSD) when assessed as adults and whether focal resection of these lesions leads to change in cognition. Methods We studied 42 adults, of whom 39 underwent focal resection targeting the lesion.
Carmen J. Zheng +4 more
wiley +1 more source
Sensorimotor Frequency Tagging Is Enhanced by Auditory and Audiovisual but Not Visual, Inputs During a Body-Walking Task. [PDF]
Matamala-Gomez M +4 more
europepmc +1 more source
Abstract Objective Long‐term memory deficits are often seen in patients with temporal lobe epilepsy (TLE). Recently, studies showed that patients with hippocampal sclerosis (HS) type 2, which presents with severe neuron loss in CA1 only, performed within the normal range. However, up to 30% of HS type 2 cases have memory deficits.
Henrique Cruz +10 more
wiley +1 more source
Respiratory and Cardiac Phase Coupling With Voluntary Actions Across Motor Tasks. [PDF]
Shibata H, Ohira H.
europepmc +1 more source
Abstract Objective This study was performed to investigate the postoperative dynamics of verbal memory function after temporal lobe resection (TLR) in people with temporal lobe epilepsy (PwTLE), with a specific focus on the course following an initial verbal memory decline and the factors influencing later changes.
Pia Langenberg +6 more
wiley +1 more source
Spontaneous Modulation of Alpha Power During a Neurofeedback Session Without Instructions. [PDF]
Maaz J, Paban V, Waroquier L, Rey A.
europepmc +1 more source
Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin +7 more
wiley +1 more source

